Article

Predictors of Fatigue 30 Days After Completing Anthracycline Plus Taxane Adjuvant Chemotherapy for Breast Cancer

Kimberly K. Wielgus

Ann M. Berger

Melody Hertzog

anthyracyclines, fatigue
ONF 2009, 36(1), 38-48. DOI: 10.1188/09.ONF.38-48

Purposes/Objectives: To identify the predictors of fatigue 30 days after completing adjuvant chemotherapy for breast cancer and whether differences are observed between a behavioral sleep intervention and a healthy-eating attention control group in predicting fatigue.

Design: Descriptive, exploratory, secondary analysis of a randomized clinical trial.

Setting: Outpatient oncology patients in a midwestern U. S. city.

Sample: 96 women, ages 29-83 years, 72% married, 95% white, diagnosed with stage I-IIIA breast cancer, receiving adjuvant anthracycline and taxane chemotherapy.

Methods: Participants were randomized to a behavioral sleep intervention group or an attention control group. Participants completed data collection prior to and during the peak and rebound days of the initial chemotherapy treatment cycle and after the last treatment.

Main Research Variables: Fatigue, circadian rhythms of activity, objective and subjective sleep-wake, and objective and subjective activity-rest.

Findings: Predictors of fatigue were less total sleep time prior to treatment, higher fatigue prior to treatment and at the peak, and less energy upon awakening on rebound days. In the control group, predictors of higher fatigue were higher fatigue prior to treatment, higher body mass index, higher number of positive lymph nodes, and less daytime dysfunction. For the intervention group, lower peak activity at the peak of initial treatment differentially predicted fatigue.

Conclusions: Results suggest the sleep intervention group participants who maintained activity balanced with sleep at the peak of the initial treatment benefited most from the intervention.

Implications for Nursing: Nurses should screen for fatigue prior to initial chemotherapy treatment and at regular intervals, further assess for poor sleep in patients who report fatigue of 4 or higher (on a 0-10 scale), and use evidence-based guidelines to select appropriate interventions.

Jump to a section

    References

    Ambulatory Monitoring, Inc. (2005). Action4(c) procedure manual. Ardsley, NY: Author.
    Ancoli-Israel, S., Cole, R., Alessi, C., Chambers, M., Moorcroft, W., & Pollak, C. P. (2003). The role of actigraphy in the study of sleep and circadian rhythms. Sleep, 26(3), 342-392.
    Ancoli-Israel, S., Liu, L., Marler, M. R., Parker, B. A., Jones, V., Sadler, G. R., et al. (2006). Fatigue, sleep, and circadian rhythms prior to chemotherapy for breast cancer. Supportive Care in Cancer, 14(3), 201-209.
    Andrykowski, M. A., Schmidt, J. E., Salsman, J. M., Beacham, A. O., & Jacobsen, P. B. (2005). Use of a case-definition approach to identify cancer-related fatigue in women undergoing adjuvant therapy for breast cancer. Journal of Clinical Oncology, 23(27), 6613-6622.
    Berger, A. M. (1998). Patterns of fatigue and activity and rest during adjuvant breast cancer chemotherapy. Oncology Nursing Forum, 25(1), 51-62.
    Berger, A. M., & Farr, L. (1999). The influence of daytime inactivity and nighttime restlessness on cancer-related fatigue. Oncology Nursing Forum, 26(10), 1663-1671.
    Berger, A. M., Parker, K. P., Young-McCaughan, S., Mallory, G. A., Barsevick, A. M., Beck, S. L., et al. (2005). Sleep/wake disturbances in people with cancer and their caregivers: State of the science [Online exclusive]. Oncology Nursing Forum, 32(6), E98-E126. Retrieved November 25, 2008, from http://ons.metapress.com/content/7244v4525u2j6408/fulltext.pdf http://ons.metapress.com/content/7244v4525u2j6408/fulltext.pdf
    Berger, A. M., Von Essen, S., Kuhn, B. R., Piper, B. F., Agrawal, S., Lynch, J. C., et al. (2003). Adherence, sleep, and fatigue outcomes after adjuvant breast cancer chemotherapy: Results of a feasibility intervention study. Oncology Nursing Forum, 30(3), 513-522.
    Berger, A. M., Von Essen, S., Kuhn, B. R., Piper, B. F., Farr, L., Agrawal, S., et al. (2002). Feasibility of a sleep intervention during adjuvant breast cancer chemotherapy. Oncology Nursing Forum, 29(10), 1431-1441.
    Bower, J. E., Ganz, P. A., Desmond, K. A., Bernaards, C., Rowland, J. H., Meyerowitz, B. E., et al. (2006). Fatigue in long-term breast cancer survivors: A longitudinal investigation. Cancer, 106(4), 751-758.
    Buysse, D. J., Reynolds, C. F., III, Monk, T. H., Berman, S. R., & Kupfer, D. J. (1989). The Pittsburgh Sleep Quality Index: A new instrument for psychiatric practice and research. Psychiatry Research, 28(2), 193-213.
    Carpenter, J. S., & Andrykowski, M. A. (1998). Psychometric evaluation of the Pittsburgh Sleep Quality Index. Journal of Psychosomatic Research, 45(1), 5-13.
    Cohen, P., Cohen, J., West, S. G., & Aiken, L. S. (2002). Applied multiple regression/correlation analysis for the behavioral sciences (3rd ed.). Mahwah, NJ: Lawrence Erlbaum Associated.
    Cole, R. J., Kripke, D. F., Gruen, W., Mullaney, D. J., & Gillin, J. C. (1992). Automatic sleep/wake identification from wrist activity. Sleep, 15(5), 461-469.
    Collins, L. M., Schafer, J. L., & Kam, C. M. (2001). A comparison of inclusive and restrictive strategies in modern missing data procedures. Psychological Methods, 6(4), 330-351.
    Ferguson, T., Wilcken, N., Vagg, R., Ghersi, D., & Nowak, A. K. (2007). Taxanes for adjuvant treatment of early breast cancer. Cochrane Database for Systematic Reviews, 17(4), CD004421.
    Fu, M., LeMone, P., McDaniel, R. W., & Bausler, C. (2001). A multivariate validation of the defining characteristics of fatigue. Nursing Diagnosis, 12(1), 15-27.
    Hosmer, D. W., & Lemeshow, S. (2000). Applied logistic regression (2nd ed.). New York: Wiley.
    Janz, N. K., Muhahid, M., Chung, L. K., Lantz, P. M., Hawley, S. T., Morrow, M., et al. (2007). Symptom experience and quality of life of women following breast cancer treatment. Journal of Women's Health, 16(9), 1348-1361.
    Jemal, A., Siegel, R., Ward, E., Hao, Y, Xu, J., Murray, T., et al. (2008). Cancer statistics, 2008. CA: A Cancer Journal for Clinicians, 58(2), 71-96.
    Lee, K., Cho, M., Miaskowski, C., & Dodd, M. (2004). Impaired sleep and rhythms in persons with cancer. Sleep Medicine Reviews, 8(3), 199-212.
    Lentz, M. J. (1990). Time-series analysis—cosinor analysis: A special case. Western Journal of Nursing Research, 12(3), 408-412.
    Littner, M., Kushida, C. A., Anderson, W. M., Bailey, D., Berry, R. B., Davila, D. G., et al. (2003). Practice parameters for the role of actigraphy in the study of sleep and circadian rhythms: An update for 2002. Sleep, 26(3), 337-341.
    Mitchell, S. A., Beck S. L., Hood L. E., Moore, K., & Tanner, E. R. (2007). Putting Evidence Into Practice®: Evidence-based interventions for fatigue during and following cancer and its treatment. Clinical Journal of Oncology Nursing, 11(1), 99-113.
    Mormont, M. C., Waterhouse, J., Bleuzen, P., Giacchetti, S., Jami, A., Bogdan, A., et al. (2000). Marked 24-h rest/activity rhythms are associated with better quality of life, better response, and longer survival in patients with metastatic colorectal cancer and good performance status. Clinical Cancer Research, 6(8), 3038-3045.
    Mullaney, D. J., Kripke, D. F., & Messin, S. (1980). Wrist-actigraph estimation of sleep time. Sleep, 3(1), 83-92.
    National Comprehensive Cancer Network. (2008). NCCN Clinical Practice Guidelines in Oncology™: Cancer-related fatigue [v.1.2008]. Retrieved November 25, 2008, from http://www.nccn.org/professionals/physician_gls/PDF/fatigue.pdf
    Page, M., Berger, A. M., & Johnson, L. B. (2006). Putting Evidence Into Practice®: Evidence-based interventions for sleep-wake disturbances. Clinical Journal of Oncology Nursing, 10(6), 753-767.
    Piper, B. F., Dibble, S. L., Dodd, M. J., Weiss, M. C., Slaughter, R. E., & Paul, S. M. (1998). The revised Piper Fatigue Scale: Psychometric evaluation in women with breast cancer. Oncology Nursing Forum, 25(4), 677-684.
    Piper, B. F., Lindsey, A. M., & Dodd, M. J. (1987). Fatigue mechanisms in cancer patients: Developing nursing theory. Oncology Nursing Forum, 14(6), 17-23.
    Prue, G., Rankin, J., Allen, J., Gracey J., & Cramp, F. (2006). Cancer-related fatigue: A critical appraisal. European Journal of Cancer, 42 (7), 846-863.
    Rich, T., Innominato, P. F., Boerner, J., Mormont, M. C., Iacobelli, S., Baron, B., et al. (2005). Elevated serum cytokines correlated with altered behavior, serum cortisol rhythm, and dampened 24-hour rest-activity patterns in patients with metastatic colorectal cancer. Clinical Cancer Research, 11(5), 1757-1764.
    Ware, J. E., Kosinski, M., & Dewey, J. E. (2000). How to score version two of the SF-36® Health Survey. Lincoln, RI: QualityMetric.
    Young-McCaughan, S., Mays, M. Z., Arzola, S. M., Yoder, L. H., Dramiga, S. A., Leclerc, K. M., et al. (2003). Change in exercise tolerance, activity and sleep patterns, and quality of life in patients with cancer participating in a structured exercise program. Oncology Nursing Forum, 30(3), 441-454.